Ethical perspectives on advances in biogerontology

[...]a hybrid approach is that life span can be extended by anti-aging medicines but with uncertain effects on health. Since all humans age, this approach implies that aging itself is not abnormal, and therefore not a disease. The latter include the increased costs of an older population. [...]longe...

Full description

Saved in:
Bibliographic Details
Published in:Aging medicine 2019-06, Vol.2 (2), p.99-103
Main Authors: Woo, Jean, Archard, Dave, Au, Derrick, Bergstresser, Sara, Erler, Alexandre, Kwok, Timothy, Newman, John, Tong, Raymond, Walker, Tom
Format: Article
Language:English
Subjects:
Aging
Bioethics
Clinical trials
Councils
Ethics
Health care
Laboratories
Legal medicine
Medical research
Older people
Robotics
Stem cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[...]a hybrid approach is that life span can be extended by anti-aging medicines but with uncertain effects on health. Since all humans age, this approach implies that aging itself is not abnormal, and therefore not a disease. The latter include the increased costs of an older population. [...]longer lives increase the temporal discounting of costs, as well as the number of productive years. Longer lives might, of course, mean more lives and thus raise population ethics issues. [...]the extensions envisaged by geroscience need not be dramatic; and the problematic pressure on global resources is a broader one than that of prolonging human lives.
ISSN:2475-0360
2475-0360
DOI:10.1002/agm2.12061